Tohoku

J. exp.

Diagnostic

Med.,

1975,

Value

116, 173-177

of Secretin

Provocation

Test

AKIRA ISHIMORI,* KATSUJI TSUDA, SUSUMU YAMAGATA, YOSHIKUNI MIURA, TAKESHI KAWAMURA, HIROYUKI SAKURADA, and SHOICHI YAMAGATA

The Third Department of Internal Medicine, Tohoku University School of Medicine, Sendai ISHIMORI, A., TSUDA, K., YAMAGATA, SU., MIURA, Y., KAWAMURA,T., SAKURADA, H. and YAMAGATA,S. Diagnostic Value of Secretin Provocation Test. Tohoku J. exp. Med., 1975, 116 (2), 173-177-Plasma gastrin response to the intravenously administered secretin was investigated in various clinical entities. The marked increase of plasma gastrin was found in response to secretin in a case of suspected Zollinger-Ellison syndrome in contrast to various degrees of plasma gastrin decrease seen in patients with ordinary or postoperative recurrent peptic ulcer. The diagnostic value of secretin provocation test was stressed especially in relation to differentiation between Zollinger-Ellison syndrome and recurrent ulcer due to retained pyloric antrum kept away from the food-passing route, both of which are characterized by hypergastrinemia and acid hypersecretion. - gastrin; secretin; peptic ulcer; Zollinger-Ellison syndrome; surgical exclusion of pyloric antrum

Since the blood gastrin-decreasing effect of secretin had been well documented (Hansky et al. 1971; Bunchman et al. 1971; Ishimori et al. 1973), the report of Isenberg et al. (1972) that the exogenously administered secretin produced significant increases in serum gastrin and gastric acid secretion in a patient with Zollinger-Ellison syndrome has been regarded to provide a reliable method in diagnosis of this syndrome. Furthermore, it has been confirmed by Bradley et al. (1973) that this unusual response of serum gastrin to secretin in the Zollinger-Ellison syndrome could not be reversed by total gastrectomy, indicating the specific na ture of pancreatic adenoma-producing gastrin. In the present investigation plasma gastrin response to the exogenously administered secretin was compared in patients with ordinary or postoperative recurrent ulcer, and a case of suspected Zollinger-Ellison syndrome, and its diagnostic value was discussed. SUBJECTS AND METHODS All patients firmed to have

with ordinary or postoperative recurrent ulcer were endoscopieally open ulcer lesions at the time of secretin provocation test.

con

A clinical diagnosis of the Zollinger-Ellison syndrome was made by confirming the coexistence of hypergastrinemia and the elevated basal acid secretion in a 21 year-old male who had a history of duodenal ulcer of about 1 year duration. In this case fasting plasma gastrin level ranged from 88 to 402 pg/ml. Normal level determined in Received for publication, March 14, 1975. * Correspondences should be addressed to Dr. Akira 173

Ishimori.

174

A. Ishimori

our

laboratory

was

AOC-tetrapeptide et

al.

of

11.8

ulcer,

1970)

revealed

mEq/hr multiple

the

stomach.

nor

metastatic

47.1•}22.8 in

a

dose

basal and

of acid

pg/ml.

Gastric

4 ƒÊg/kg

body

output

BAO/MAO

scar

of

formations

Angiography lesion.

were and

The

patient

at

observed

is

of the

scintigraphy

analysis weight

(BAO) 0.9

et al.

10.7

time

the

mEq/hr, of

the

under

the

and

periodic

the liver

by

(Yamagata

acid Besides

and

stimulation

stimulus

maximal

along

pancreas

after

maximal

admission.

endoscopically of

still

before as

output open

lesser revealed

(MAO) duodenal

curvature no

of tumor

observations.

Following multiple sampling of fasting blood in 40 to 60 min, secretin (Boots Pure Drug Co., England) of either 1 or 3 emits/kg body weight was injected intravenously in 3 min and blood specimen was collected frequently thereafter. In most of the cases, intragastric pH was measured simultaneously during the experiment using PH Telemetering Capsule Model TPH-04 (Matsushita Elect. Indust. Co., Osaka, Japan). Plasma gastrin was assayed by the charcoal method using a kit available from the CEA-IRE-SORIN association.

RESULTS

An average response of plasma gastrin in 16 patients with peptic ulcer to secretin 1 unit/kg body weight was shown in Fig. 1. A tendency of plasma gastrin to decline was seen around 10 min after the administration of secretin, although it was not significant statistically. It is noticed that plasma gastrin level remained within normal limits during the test in this group. Fig. 2 demonstrates the decrease in plasma gastrin in response to secretin observed clearly in a case of recurrent ulcer due to retained pyloric antrum kept away from the food-passing route. Fasting plasma gastrin was maintained relatively constant around 450 pg/ml in this case. In Fig. 3 the paradoxical response of plasma gatrin to secretin observed in a case of suspected Zollinger-Ellison syndrome was shown. The highest peak of plasma gastrin seen at 10 min after administration of secretin 3 units/kg body weight recorded 1100 pg/ml which exceeded the relatively high level of fasting plasma gastrin by nearly 900 pg/nil.

Fig.

1. Response Shaded area

of plasma represents

indicate S.D.

n=16.

gastrin to exogenous secretin in patients with the normal range of fasting plasma gastrin .

peptic

ulcer . Vertical bars

Diagnostic

Value

of Secretin

Provocation

Test

175

Fig. 2. Response of plasma gastrin to exogenous secretin in a case (G.M., 33 years old male) of recurrent ulcer due to retained pyloric antrum kept away from the food passing route. Shaded area represents the normal range of fasting plasma gastrin.

Fig. 3. Paradoxical response of plasma gastrin to exogenous secretin in a case (Y.S., 21 years old male) of suspected Zollinger-Ellison syndrome. Shaded area represents the normal range of fasting plasma gastrin.

Fig. 4 illustrates the responses in intragastric pH and plasma gastrin level in a case of peptic ulcer which showed a false positive results probably due to an eleva tion of intragastric pH. However, it is noted that the increase of plasma gastrin in response to secretin was just minimal. DISCUSSION It that

the

has

been

release

reported of gastrin

concerning from

the

pancreatic

diagnosis

of Zollinger-Ellison

adenoma

fluctuates

variably

syndrome resulting

in

176

Fig.

A. Ishimori

4.

Simultaneous

years

old

plasma

measurement

male)

of

gastrin. •ü,

peptic plasma

of plasma ulcer.

Shaded

gastrin; •œ,

et al.

gastrin area

and

intragastric

represents

intragastric

pH

the

in

normal

a case range

(A.T., of

21

fasting

pH.

the change in acid secretion of the stomach (Winship and Ellison 1967; Thompson et al. 1972). Therefore, typical hypergastrinemia could not be expected in all cases of Zollinger-Ellison syndrome especially in the early stage. could

On the contrary not guarantee

it is also pointed the diagnosis

postoperative recurrent ed pyloric antrum kept hypergastrinemia

out that even a finding of hypergastrinemia of Zollinger-Ellison syndrome in cases

ulcer, since certain operative away from the food-passing

and hypersecretion

of gastric

of

procedures which leave retain route may lead to develop both

acid in patients

with ordinary

peptic

ulcer. It method

is clear,

therefore,

is necessary

that

to differentiate

the

development the

of another

Zollinger-Ellison

reliable

syndrome

from

diagnostic ordinary

peptic ulcer in these border line or operated cases. The secretin provocation was examined from such a point of view in the present investigation.

test

As to diagnosis of border line cases which do not show typical hypergastrinemia, the secretin provocation test was found to be useful to differentiate the ZollingerEllison syndrome from ordinary peptic ulcer as shown in Figs. 1 and 3. However, false positive results can be obtained occasionally as shown in Fig. 4 owing to the elevation of intragastric pH which promotes the release of gastrin from gastric mucosa into blood stream through the negative feedback mechanism. The eleva tion of intragastric pH may be caused by direct inhibition of acid secretion at the parietal cell level (Johnson and Grossman 1969; Chey et al. 1970; Ishimori et al. 1973) and by regurgitation of alkaline duodenal content into the stomach. Therefore, it is recommended to measure intragastric pH simultaneously during the secretin provocation test in order to discriminate false positive results. Anyway it would be safe that the minimal increase of plasma gastrin is interpreted as an indication of further examination. In general the secretin provocation test is regarded to be useful in diagnosis of border line cases as already stated by Saeuberli et al. (1974).

Diagnostic

Value

of Secretin

Provocation

Test

177

An application of secretin provocation test to the differentiation of Zollinger - Ellison syndrome and recurrent ulcer due to retained pyloric antrum kept away from the food-passing route has never been reported to our knowledge. Since both conditions could show hypergastrinemia and acid hypersecretion , and since a suspicion of Zollinger-Ellison syndrome could be placed for the first time on postoperative recurrence of ulcer, the establishment of a reliable diagnostic method is quite important for treatment. Indeed the case of postoperative recurrent ulcer presented here has been successfully treated by the repair of the food-passing route. It should be mentioned concerning the reliability of this test that vagotomy does not alter the preoperative response of blood gastrin to secretin as reported by Me Laughlin et al. (1974). Although

the mechanism

with ordinary - Ellison

peptic

syndrome,

indicate

remains

the usefulness

- Ellison

by which

secretin

ulcer, while it increases unsolved,

decreases

the results

of the secretin

blood gastrin

blood gastrin

in patients

obtained

provocation

in patients

with Zollinger

in the present

investigation

test for the diagnosis

of Zollinger

syndrome. References

1)

Bradley,

E.L.,

relationship 2)

Bunchman, gastrin

Chey,

W.Y.,

58,

Hitanant,

J.,

J.I.,

H.

&

Y.K.

73,

in

(1973)

(1971)

Effect

Surg.

Lorber,

Secretin-gastrin

550-556.

dog. S.H.

gastric

of

Forum,

(1970)

secretion

Me

H.,

.

Die

secretin 22,

Effect

in

on

the

303-304. of secretin

man.

and

Gastroenterology,

J.C., measurements

Winship,

D.H.

without

1970)

& the

Yamagata, Nose,

F.

S., T.,

Gastric Med.,

101,

M.,

&

the

secretion 103-117.

in

&

Saik,

R.P.

66,

gastrin

as

Grossman,

M.I.

gastric

acid

Tsuda,

secretory

62, K.,

626-631.

Shimoyama,

response

gastric

(1972) secretion

of

and

M.,

the

stomach

duodenal

ulcer.

W.

E.H.

104,

K.,

stimulated

Human

Das

of

gastric

secre

A.,

by

response

to

Gastrin. ‡U bei

verschiedenen

745-751. H.H.

Variability

Uematsu,

gastrin

Magenantrumhormon

(1972)

syndrome.

syndrome. Ishimori,

inhibition

Gastrinbestimmung

Bunchman,

(1967)

(1974)

(1974)

der

&

of

743.

Zollinger-Ellison

H.,

&

Gastroenterology,

Characteristics

Vetter,

D,D.

Kawai,

serum

1401-1404.

med. Wocheaschr.,

Ellison,

on

and

T.,

between

217,

Zollinger-Ellison

Masuda,

Masuda,

syndrome.

Bedeutung

in

E.W.

Kawamura,

(1969)

G.W.

Reeder,

secretin

calcium,

Difference

Physiol.,

praktische

Moore,

serum

Gastroenterology,

Largiader,

of

62-68.

353-362.

Peskin,

Schweiz.

Thompson,

Jr.,

Y.,

(1973)

M.I. J.

vagotomy.

Saeuberli,

and

Grossman,

M.H.,

post

E.,

depressants 8,

Amer.

Laughlin,

Teil:

S.

Effect

61,

gastrin,

Miura,

secretory

&

secretin.

(1971)

Zollinger-Ellison

japonica, L.R.

by

M.G.

serum

Su.,

Yamagata,

gastric

Johnson,

exp.

J.

Passaro,

on

suspected

&

various

gastrin

12)

Chan,

J.C.

and

and

Korman,

J.H.,

Yamagata,

Krankheiten.

11)

Hendricks,

&

secretin

with A.,

ecretin

10)

man

Gastroenterology,

Walsh,

Gastroenterologia

tion

C.

of

a patient

Ishimori,

to

9)

Thompson,

in

emptying

immunoassay.

effect

akurada,

8)

S.,

&

Surgery,

&

a meal

gastric

Soveny, by

Isenberg,

in

7)

C.R.

820-827.

Hansky,

Unusual

6)

D.D. to

in

measured 5)

Lobley, syndrome.

Reeder,

response

cholecystokinin

4)

J.T.,

Zollinger-Ellison

H.H.,

serum 3)

Galambos, in

of Lancet,

Inoue,

S., T.,

gastrin-like

Clinical

Amer. gastric 1,

role

Surg.,

secretion

of

124, in

serum

250-261.

patients

with

Kinoshita,

H.,

1128-1130.

Wada,

Sato,

J.

T., H.,

Sato,

Yunoki,

AOC-tetrapeptide.

K., K.

&

Sasahira, Tohoku

S. J.

Diagnostic value of secretin provocation test.

Plasma gastrin response to the intravenously administered secretin was investigated in various clinical entities. The marked increase of plasma gastri...
326KB Sizes 0 Downloads 0 Views